Efficacy of Rifaximin in Treatment of Cirrhotic Gastroesophageal Variceal Bleeding

Clinical trial NCT02964195 · UNKNOWN

Trial details

NCT number: NCT02964195
Sponsor: Shanghai Zhongshan Hospital
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Cirrhosis Esophageal and Gastric Varices Gastrointestinal Hemorrhage

Start date: 2016-11-01
Primary completion: 2017-10-01
Enrollment: 308

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.